Viewing Study NCT00128232


Ignite Creation Date: 2025-12-24 @ 9:37 PM
Ignite Modification Date: 2026-04-08 @ 4:44 AM
Study NCT ID: NCT00128232
Status: COMPLETED
Last Update Posted: 2012-04-30
First Post: 2005-08-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acromegaly View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acromegaly View
None untreated View
None newly diagnosed View
None octreotide LAR View